13 patients (22.03%) in the upper PCSK9 tertile experienced a clinical MACEs (CV death, MI, unstable angina, stent thrombosis, repeat revascularization and IS), compared with 2 (3.39%) in the lower PCSK9 tertile. This evidence concerns the gene PCSK9 and angina pectoris.